Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia

Communications in Clinical Cytometry

Volumn 30, Issue 2, 1997, Pages 98-102

  Escribano, Luis ^a   Orfao, Alberto ^b,e   Villarrubia, Jesús ^a   Martín, Flor ^c   Madruga, José I ^c   Cuevas, Manuela ^d   Velasco, Jose L ^a   Rios, Agusta ^e   San Miguel, Jesús F ^e  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c Hospital General de Zamora   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

flow cytometry; immunophenotype; mast cells; systemic mast cell disease

Indexed keywords

CELL ADHESION MOLECULE; GROWTH FACTOR RECEPTOR;

AGED; ARTICLE; CASE REPORT; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MAST CELL; MAST CELL LEUKEMIA; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; INTERFERON ALFA-2B; LEUKEMIA, MAST-CELL; MAST CELLS; MASTOCYTOSIS;

EID: 0030900209     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9     Document Type: Article

References (32)

1. Dvorak AM, Schulman ES, Peters SP, MacGlashan DW, Newball HH, Schleimer RP, Lichtenstein LM: Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest 53:45-56, 1985.
2. Escrihano L, Orfao A, Villarrubia J, Cerveró C, Velasco JL, Martin F, San Miguel JF, Navarro JL: Expression of lymphoid-associated antigens in mast cells: Report of a case of systemic mast cell disease. Br J Haematol 91:941-943, 1995.
3. Födinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C: Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84:2954-2959, 1994.
4. Froese A: Receptors for IgE on mast cells and basophils Prog Allergy 34:142-187, 1984.
5. Guo C-B, Kagey-Sobotka A, Lichtenstein IM, Bochner BS: Immunophenotyping and functional analysis of purified human uterine mast cells. Blood 79:708-712, 1992.
6. Hamamoto K, Ohga S, Nomura S, Yasunaga K: Cellular distribution of CD63 antigen in platelets and in three megakaryocytic cell lines. Histochem J 26:367-375, 1994.
7. Hara T, Jung LKL, Bjorndahl JM, Fu SM: Human T cell activation III. Rapid induction of a phosphorylated 28kD/32kD disulfide-linked early activation antigen (EA 1) by 12-o-Tetradecanoyl phorbol-13-acetate, mitogens, and antigens J Exp Med 164:1988-2005, 1986.
8. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ: CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80:281-286, 1993.
9. Helm B, Marsh P, Vercelli D, Padlan E, Gould H, Geha R: The mast cell binding site on human immunoglobulin E. Nature 331:180-183, 1988.
10. Ishizaka Klshizaka T: Immunoglobulin E. Byosynthesis and immunological mechanism of IgE-mediated hypersensitivity In: Cellular, Molecular and Clinical Aspects of Allergic Disorders, Gupta L, Good M, (eds). New York: Plenum Press, 1979, pp. 153-178.
11. Ishizaka T: Analysis of triggering events in mast cells for immunoglobulin E mediated histamine release. J Allergy Clin Immunol 67:90-96, 1981.
12. Ishizaka T, Ishizaka K: Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188-235, 1984.
13. Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, Willemze R: Response to interferon ALFA-2b in a patient with systemic mastocytosis. N EnglJ Med 326:619-623, 1992.
14. Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D: Monitoring human basophil activation via Cd63 monoclonal antibody. J Allergy Clin Immunol 88:328-338, 1991.
15. Lanza F, Moretti S, Papa S, Malavasi F, Castoldi G: Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993. Haematologica 79:374-386, 1994.
16. Maggiano N, Colotta F, Castellino F, Ricci R, Valitutti S, Larocca LM, Musiani P: Interleukin-2 receptor expression in human mast cells and basophils. Int Arch Allergy Appl Immunol 91:8-14, 1990.
17. Metcalfe DD: Clinical advances in mastocytosis: An interdisciplinary roundtable discussion. J Invest Dermatol 96:suppl:1S-65S, 1991.
18. Metezelaar MJ, Sixma JJ, Nieuwenhuis HK: A new cluster of activation-dependent monoclonal mAb recognizes a 53-kDa lisosome-like granule protein, expressed on the plasma membrane after activation In: Leukocyte Typing IV, 4th ed, Knapp W, Dorken E, Rieber H, Stein H, Gilks WR, Schmidt RI, von der Borne AEGR (eds). New York: Oxford University Press, 1989, pp. 1043-1044.
19. Metzger H: The high affinity receptor for IgE on mast cells. Clin Exp Allergy 21:269-279, 1991.
20. Mirowski G, Austen KF, Chiang L, Horan RF, Sheffer AL, Weidner N, Murphy GF: Characterization of cellular dermal infiltrates in human cutaneous mastocytosis. Lab Invest 63:52-62, 1990.
21. Orfao A, Escribano L, Villarrubia J, Velasco JL, Cerveró C, Ciudad J, Navarro JL, San Miguel JF: Flow cytometric identification and enumeration of mast cells from both normal and pathological human hone marrow samples. Am J Pathol 149:1493-1499, 1996.
22. Orfao A, García-Sanz R, López-Berges MC, Vidriales MB, González M, Caballero MD, San Miguel JF: A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/ propidium iodide double staining technique. Cytometry 17:332-339, 1994
23. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J, Slot JW, Geuze HJ: Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perform and granzymcs. J Exp Med 173:1099-1109, 1991.
24. Sperr WR, Bankl HC, Mundigler G, Klappacher G, Grossschmidt K, Agis H, Simon P, Laufer P, Imhof M, Radaszkiewicz T, Glogar D, Lechner K, Valent P: The human cardiac mast cell: Localization, isolation, phenotype, and functional characterization. Blood 84:3876-3884, 1994.
25. Testi R, D'Ambrosio D, De Maria R, Santoni A: The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15:479-483, 1994.
26. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A: CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med 172:701-707, 1990.
27. Travis WD, Li CY, Hoagl HC, Travis LB, Banks PM: Mast cell leukemia: Report of a case and review of the literature. Mayo Clin Proc 61:957-966, 1986.
28. Valent P: The phenotype of human eosinophils, basophils, and mast cells. J Allergy Clin Immunol 94 Suppl. 1177-1183, 1994.
29. Valent P, Ashman LK, Hinterberger W, Eckersberger F, Majdic O, Lechner K, Bettelheim P: Mast cell typing: Demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 73:1778-1785, 1989.
30. Valent P, Bettelheim P: Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv Immunol 52:333-423, 1992
31. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P: Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 91:198-203, 1990
32. Vindelov LL, Christehnsen IBJ, Jensen G, Nissen NI: Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis: results obtained by a set of methods for sample storage, staining and internal standardization. Cytometry 3:332-338, 1983